Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice
about
Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueThe flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model miceIVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathologyAge-related intraneuronal elevation of αII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3×Tg-AD miceOral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD miceDeficits in memory-guided limb movements impair obstacle avoidance locomotion in Alzheimer's disease mouse modelHuman neural stem cells alleviate Alzheimer-like pathology in a mouse model.Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment and Chronic Neurobehavioral Changes.Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease.Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice.PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and AβIntranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD miceSpatial frequency domain imaging of intrinsic optical property contrast in a mouse model of Alzheimer's diseaseAge-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice.Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic miceStaging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.Animal models of amyloid-beta-related pathologies in Alzheimer's disease.Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD miceTFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease.Increased hippocampal excitability in the 3xTgAD mouse model for Alzheimer's disease in vivo.Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice.3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.Age-related loss of noradrenergic neurons in the brains of triple transgenic mice.A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.
P2860
Q26852041-031E9843-3039-4474-A116-65392ACBDB40Q27305145-325D2C3E-8CA4-4BA2-A5A1-3B2344D1E5FFQ27497796-2D0D163B-5827-4E54-AA5E-808497292C75Q28728312-197E64F1-E13F-414A-8E3E-699BB58DA043Q30277388-550C5163-0842-4E72-B353-D84542DC942EQ30415876-533ED09D-BB85-43CF-BF15-49CF416A99C7Q30573779-12F07C3B-113F-402F-8CE3-6C1F77CD9421Q30602249-4DC94310-901D-4297-9D67-51B06E813549Q30662068-F2819AA4-C5FC-432A-855B-CB2C9E9A3250Q30848300-C4E5FE78-C174-4C74-9286-C69B41E6D975Q31108663-63107F63-56E0-4A9B-8A50-301589D83A1DQ33605644-65E8953C-BFA0-442D-901E-558E92B84DD7Q33605706-E22C998D-0A8E-4092-A242-969DD505D299Q33687674-79A62757-C4C7-4D3B-8B2D-A4C2B8E2ECF1Q33823745-3588589D-5D61-4003-998A-1E3494AD3F95Q34003920-14E3616C-8C35-488B-9108-61580411AF1EQ34043269-170410EA-A4C3-48F5-B5FE-1C559570D552Q34078130-D336222A-FB86-4709-A32A-2CFB8E384A0CQ34086988-60562F2E-8C6A-42B6-9E18-DBEB1945C9EDQ34097190-9821DEFB-3CCD-478A-ABD8-2313867AA243Q34127161-AAE51ABD-E7A3-4298-AE03-F81D14BDEC2EQ34388949-81F50C03-0684-4F96-B90F-A638ABCB733CQ34459388-EAF7F3D6-56F1-4C37-8276-88DB6086CE62Q34477111-C2D3008A-BF15-4E53-8AFA-23507E457800Q34479091-79EBD382-AF86-4EA6-B325-C065A0BC6018Q34549221-C3390409-2040-4702-9729-BB755DDF6DFFQ34659234-A713A167-0D40-4E66-99BB-39F05F6D9F67Q35055819-F5003B4B-987D-4355-8A40-22B3007BF223Q35118753-7EBF4FD6-712F-4DE4-9F5E-9AA0EB4FD823Q35148785-037F5C00-E17C-4FA0-A1E3-6B1049664269Q35235768-4664AB0E-7DE9-4E59-AC54-4EB1C29D7B10Q35583236-04FEEB06-27F5-4EDC-9425-F1CB864A5057Q35852564-ADD941ED-DCEF-4AA2-BCAA-90DB3FE6D64BQ35890955-BA8D85D3-520E-4427-9286-52090C208BD1Q36421740-3BEB5ED6-E3C1-4E35-A31C-F08A12AF7DD9Q36476316-DB32486C-6274-43CC-9EF5-49B3FC1A5CFEQ36528293-5766E600-6BD6-47FC-9226-1AF93C257368Q36640367-F2E1AD2D-213B-47E8-B015-B608B8A34B25Q36799810-1B9BB632-9A41-4696-95CF-0A6B79156D2AQ36950042-B35EF82C-0DAC-491F-A951-C56318FBD83F
P2860
Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Detailed immunohistochemical c ...... in male triple-transgenic mice
@ast
Detailed immunohistochemical c ...... in male triple-transgenic mice
@en
type
label
Detailed immunohistochemical c ...... in male triple-transgenic mice
@ast
Detailed immunohistochemical c ...... in male triple-transgenic mice
@en
prefLabel
Detailed immunohistochemical c ...... in male triple-transgenic mice
@ast
Detailed immunohistochemical c ...... in male triple-transgenic mice
@en
P2860
P356
P1433
P1476
Detailed immunohistochemical c ...... in male triple-transgenic mice
@en
P2093
Michael A Mastrangelo
William J Bowers
P2860
P2888
P356
10.1186/1471-2202-9-81
P577
2008-08-12T00:00:00Z
P5875
P6179
1005996533